Literature DB >> 8261813

Serum alanine aminotransferase (ALT) elevation in asymptomatic US Air Force basic trainee blood donors.

L W Kundrotas1, D J Clement.   

Abstract

The purpose of this study was to determine the etiology of elevated alanine aminotransferase (ALT) in a population of asymptomatic volunteer blood donors. Subjects with an ALT value > 2.25 sd above norm (> 55 IU/liter) from the donated unit, were prospectively evaluated over a six-week interval. The subjects consisted of blood donors (78% male, 22% female) beginning basic military training at Lackland Air Force Base. Of 44,160 individuals screened, 19,877 (45%) voluntarily donated blood, 99 (0.5%) of which had confirmed ALT elevation. Of these (90 male/9 female), an associated condition or explanation was made in 12%: four with acute hepatitis B, four positive for anti-HCV, two with autoimmune disease, one with cholelithiasis and one associated with acute appendicitis. In 87 the ALT elevation could not be explained using available testing methods but may represent individual variation from a non-Gaussian distribution, be of nonhepatic origin (muscle), or of hepatic disease not detected by the diagnostic algorithm used. To increase the diagnostic yield, it is suggested that at least two elevated ALT values be established in this population over a period of time (yet undefined), before an extensive hepatic investigation is pursued.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8261813     DOI: 10.1007/bf01299887

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  15 in total

1.  Evaluation of blood donors with elevated serum alanine aminotransferase levels.

Authors:  L S Friedman; J L Dienstag; E Watkins; C A Hinkle; J A Spiers; S V Rieder; C E Huggins
Journal:  Ann Intern Med       Date:  1987-08       Impact factor: 25.391

2.  The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients.

Authors:  J E Hay; A J Czaja; J Rakela; J Ludwig
Journal:  Hepatology       Date:  1989-02       Impact factor: 17.425

3.  The yield of multiphasic screening.

Authors:  B Bates; J A Yellin
Journal:  JAMA       Date:  1972-10-02       Impact factor: 56.272

4.  Plasma enzyme activities in primary hypothyroidism.

Authors:  G H White; R N Walmsley
Journal:  Clin Chem       Date:  1984-02       Impact factor: 8.327

5.  Correlation between tests of muscle involvement and clinical muscle weakness in polymyositis and dermatomyositis.

Authors:  K E Tymms; E M Beller; J Webb; L Schrieber; W W Buchanan
Journal:  Clin Rheumatol       Date:  1990-12       Impact factor: 2.980

6.  Plasma activity of muscle enzymes: quantification of skeletal muscle damage and relationship with metabolic variables.

Authors:  G M Janssen; H Kuipers; G M Willems; R J Does; M P Janssen; P Geurten
Journal:  Int J Sports Med       Date:  1989-10       Impact factor: 3.118

7.  Adverse effects of three different forms of heparin therapy: thrombocytopenia, increased transaminases, and hyperkalaemia.

Authors:  M Monreal; E Lafoz; R Salvador; J Roncales; A Navarro
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 8.  The enzymology of skeletal muscle disorders.

Authors:  J A Lott; P W Landesman
Journal:  Crit Rev Clin Lab Sci       Date:  1984       Impact factor: 6.250

9.  Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases.

Authors:  R Hultcrantz; H Glaumann; G Lindberg; L H Nilsson
Journal:  Scand J Gastroenterol       Date:  1986-01       Impact factor: 2.423

Review 10.  Alanine aminotransferase in clinical practice. A review.

Authors:  K E Sherman
Journal:  Arch Intern Med       Date:  1991-02
View more
  13 in total

1.  [Monitoring of hypertransaminasaemia in primary care clinics].

Authors:  A Ortega Carpio; M Mora García; P Batalha Caetano; R Fernández Leal
Journal:  Aten Primaria       Date:  2003-10-15       Impact factor: 1.137

2.  Sensitivity and specificity of tests of liver injury.

Authors:  Vinoo Cameron
Journal:  Clin Med Res       Date:  2004-11

Review 3.  Tests of liver injury.

Authors:  Kenneth A Musana; Steven H Yale; Ahmad S Abdulkarim
Journal:  Clin Med Res       Date:  2004-05

4.  Reexamining transaminase elevation in Phase I clinical trials: the importance of baseline and change from baseline.

Authors:  Zhaohui Cai; Anastasia M Christianson; Lars Ståhle; Marianne Keisu
Journal:  Eur J Clin Pharmacol       Date:  2009-06-25       Impact factor: 2.953

5.  Elevated serum aminotransferases secondary to rippling muscle disease.

Authors:  Kumanan Nalankilli; John Lubel
Journal:  Case Rep Gastroenterol       Date:  2013-05-24

6.  Correlation of Body Mass Index and Serum Parameters With Ultrasonographic Grade of Fatty Change in Non-alcoholic Fatty Liver Disease.

Authors:  Ghobad Abangah; Atefeh Yousefi; Rouhangiz Asadollahi; Yousef Veisani; Paria Rahimifar; Sajjad Alizadeh
Journal:  Iran Red Crescent Med J       Date:  2014-01-05       Impact factor: 0.611

7.  Prevalence and factors of elevated alanine aminotransferase in central Taiwan - a retrospective study.

Authors:  Hsien-Feng Lin; Shih-Wei Lai; Wen-Yuan Lin; Chiu-Shong Liu; Cheng-Chieh Lin; Ching-Mei Chang
Journal:  Biomedicine (Taipei)       Date:  2016-05-09

8.  Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects.

Authors:  S Kechagias; A Ernersson; O Dahlqvist; P Lundberg; T Lindström; F H Nystrom
Journal:  Gut       Date:  2008-02-14       Impact factor: 23.059

Review 9.  Mild Hypertransaminasemia in Primary Care.

Authors:  Said A Al-Busafi; Nir Hilzenrat
Journal:  ISRN Hepatol       Date:  2013-04-10

10.  Low yield of unselected testing in patients with acutely abnormal liver function tests.

Authors:  Andrew Chadwick; Michael Marks
Journal:  JRSM Open       Date:  2015-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.